Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: P2C 9170 Principal Investigator: Ma, Cynthia
Title: A Phase II Trial of Neoadjuvant MK-2206 in Combination with either Anastrozole if Postmenopausal or Anastrozole and Goserelin if Premenopausal in Women with Clinical Stage 2 or 3 PIK3CA Mutant Estrogen Receptor Positive and HER2 Negative Invasive Breast Cancer
Phase: II Disease Site: Breast, Female
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this research study is to find out what effects, good and/or bad, the drug MK-2206 in combination with anastrozole with or without goserelin (depending on menopausal status) has on patients and their breast cancer.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)